4.7 Article

Association between Neuroligin-1 polymorphism and plasma glutamine levels in individuals with autism spectrum disorder

期刊

EBIOMEDICINE
卷 95, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.ebiom.2023.104746

关键词

Autism spectrum disorder; Endophenotype; Glutamine; Neuroligin-1; Glutamine-glutamate cycle; Excitatory-inhibitory imbalance

向作者/读者索取更多资源

This study found an association between plasma glutamine levels and clinical phenotypes in individuals with autism spectrum disorder (ASD), suggesting that plasma glutamine levels could serve as an endophenotype linking genetic risk and symptom severity. These findings may contribute to the development of novel therapeutic targets, selection of specific cohorts for clinical trials, and identification of target symptoms for future ASD treatment strategies.
Background Unravelling the relationships between candidate genes and autism spectrum disorder (ASD) phenotypes remains an outstanding challenge. Endophenotypes, defined as inheritable, measurable quantitative traits, might provide intermediary links between genetic risk factors and multifaceted ASD phenotypes. In this study, we sought to determine whether plasma metabolite levels could serve as endophenotypes in individuals with ASD and their family members.Methods We employed an untargeted, high-resolution metabolomics platform to analyse 14,342 features across 1099 plasma samples. These samples were collected from probands and their family members participating in the Autism Genetic Resource Exchange (AGRE) (N = 658), compared with neurotypical individuals enrolled in the PrecisionLink Health Discovery (PLHD) program at Boston Children's Hospital (N = 441). We conducted a metabolite quantitative trait loci (mQTL) analysis using whole-genome genotyping data from each cohort in AGRE and PLHD, aiming to prioritize significant mQTL and metabolite pairs that were exclusively observed in AGRE.Findings Within the AGRE group, we identified 54 significant associations between genotypes and metabolite levels (P < 5.27 x 10(-11)), 44 of which were not observed in the PLHD group. Plasma glutamine levels were found to be associated with variants in the NLGN1 gene, a gene that encodes post-synaptic cell-adhesion molecules in excitatory neurons. This association was not detected in the PLHD group. Notably, a significant negative correlation between plasma glutamine and glutamate levels was observed in the AGRE group, but not in the PLHD group. Furthermore, plasma glutamine levels showed a negative correlation with the severity of restrictive and repetitive behaviours (RRB) in ASD, although no direct association was observed between RRB severity and the NLGN1 genotype. Interpretation Our findings suggest that plasma glutamine levels could potentially serve as an endophenotype, thus establishing a link between the genetic risk associated with NLGN1 and the severity of RRB in ASD. This identified association could facilitate the development of novel therapeutic targets, assist in selecting specific cohorts for clinical trials, and provide insights into target symptoms for future ASD treatment strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据